Louis Ferrari
Keine laufenden Positionen mehr
Karriereverlauf von Louis Ferrari
Ehemalige bekannte Positionen von Louis Ferrari
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SAVIENT PHARMACEUTICALS INC | Direktor/Vorstandsmitglied | 10.07.2012 | 20.06.2013 |
| Vorstandsvorsitzender | 09.07.2012 | 20.06.2013 | |
| Corporate Officer/Principal | 16.02.2011 | 10.07.2012 | |
| Präsident | 10.07.2012 | 20.06.2013 |
Ausbildung von Louis Ferrari
| Adelphi University | Masters Business Admin |
| Arnold & Marie Schwartz College of Pharmacy & Health Science | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 4 |
Operativ
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
| Corporate Officer/Principal | 1 |
Sektoral
| Consumer Services | 3 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Savient Pharmaceuticals, Inc.
 Savient Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Savient Pharmaceuticals, Inc. operates as a specialty biopharmaceutical company, which develops, manufactures and markets pharmaceutical products. The company focuses on developing and commercializing KRYSTEXXA for the treatment of chronic gout in adult patients who do not respond to conventional therapy. It also sells and distributes branded and generic versions of oxandrolone, a drug used to promote weight gain following involuntary weight loss. The company was founded in 1980 is headquartered in East Brunswick, NJ. | Health Technology |
- Börse
- Insiders
- Louis Ferrari
- Erfahrung
